Dostarlimab
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB15627 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | atrichia with papular lesions | KG + DL |
| 2 | familial primary hyperparathyroidism | KG + DL |
| 3 | lung occult squamous cell carcinoma | KG + DL |
| 4 | multiple acyl-CoA dehydrogenase deficiency, severe neonatal type | KG + DL |
| 5 | epsilon-heavy chain disease | KG + DL |
| 6 | carcinoma of esophagus | KG + DL |
| 7 | pemphigus and fogo selvagem | KG + DL |
| 8 | symmetrical thalamic calcifications | KG + DL |
| 9 | cryptogenic organizing pneumonia | KG + DL |
| 10 | microcephalic osteodysplastic primordial dwarfism types I and III | KG + DL |
| 11 | acute liver failure | KG + DL |
| 12 | AAT1 | KG + DL |
| 13 | Electroencephalographic peculiarity: occipital slow beta waves | KG + DL |
| 14 | acquired aneurysmal subarachnoid hemorrhage | KG + DL |
| 15 | autoimmune oophoritis | KG + DL |
| 16 | brucellosis | KG + DL |
| 17 | nephrogenic systemic fibrosis | KG + DL |
| 18 | diffuse alveolar hemorrhage (disease) | KG + DL |
| 19 | post-traumatic epilepsy | KG + DL |
| 20 | isolated ectopia lentis | KG + DL |
| 21 | mammary neoplasms, animal | KG + DL |
| 22 | FBLN1-related developmental delay-central nervous system anomaly-syndactyly syndrome | KG + DL |
| 23 | esterase | KG + DL |
| 24 | bilateral renal agenesis | KG + DL |
| 25 | myositis ossificans | KG + DL |
| 26 | progressive multifocal leukoencephalopathy | KG + DL |
| 27 | optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome | KG + DL |
| 28 | situs ambiguus | KG + DL |
| 29 | epiphyseal dysplasia-hearing loss-dysmorphism syndrome | KG + DL |
| 30 | fragile site 10Q23 | KG + DL |
| 31 | Lhermitte-Duclos disease | KG + DL |
| 32 | diabetic peripheral angiopathy | KG + DL |
| 33 | Lyme disease | KG + DL |
| 34 | tuberculous fibrosis of lung | KG + DL |
| 35 | benign cephalic histiocytosis | KG + DL |
| 36 | middle cerebral artery infarction | KG + DL |
| 37 | Rift valley fever | KG + DL |
| 38 | gastric sneezing | KG + DL |
| 39 | Turner syndrome due to structural X chromosome anomalies | KG + DL |
| 40 | ischemia reperfusion injury | KG + DL |
| 41 | HSD10 disease, neonatal-infantile | KG + DL |
| 42 | Prader-Willi-like syndrome | KG + DL |
| 43 | acute encephalopathy with biphasic seizures and late reduced diffusion | KG + DL |
| 44 | 2q23.1 microduplication syndrome | KG + DL |
| 45 | glucose-6-phosphate dehydrogenase-like | KG + DL |
| 46 | multiple epiphyseal dysplasia due to collagen 9 anomaly | KG + DL |
| 47 | bagassosis | KG + DL |
| 48 | paraneoplastic pemphigus | KG + DL |
| 49 | ureteritis | KG + DL |
| 50 | X-linked Ehlers-Danlos syndrome | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.